DEVELOPMENT OF ANTI-HUMAN-B BLOOD GROUP MONOCLONAL-ANTIBODIES SUITABLE AS A BLOOD TYPING REAGENT

dc.contributor.authorBECKER, MI
dc.contributor.authorJUICA, F
dc.contributor.authorJAMETT, A
dc.contributor.authorTZICHINOVSKY, S
dc.contributor.authorBARROS, S
dc.contributor.authorAGUAYO, J
dc.contributor.authorDEIOANNES, AE
dc.date.accessioned2025-01-21T01:35:20Z
dc.date.available2025-01-21T01:35:20Z
dc.date.issued1994
dc.description.abstractAn improved procedure for the generation of high-avidity anti-human B blood group monoclonal antibodies (MAbs) was developed. One of them, termed 7A1-2, showed excellent qualities of titer, avidity, and intensity required For use as human B blood typing reagent. Hemagglutination inhibition studies with monosaccharides and oligosaccharides were carried out to determine the specificity of the MAb 7A1-2. These studies indicate that the antibody reacts with the immunodominant region of the antigen which is known to confer the serologic specificity of this blood group.
dc.fuente.origenWOS
dc.identifier.issn0272-457X
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/97669
dc.identifier.wosidWOS:A1994PQ89200007
dc.issue.numero4
dc.language.isoen
dc.pagina.final310
dc.pagina.inicio303
dc.revistaHybridoma
dc.rightsacceso restringido
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleDEVELOPMENT OF ANTI-HUMAN-B BLOOD GROUP MONOCLONAL-ANTIBODIES SUITABLE AS A BLOOD TYPING REAGENT
dc.typeartículo
dc.volumen13
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files